The purpose of this study was to evaluate whether an investigational medicine could reduce the risk of major heart related events (such as heart attack or stroke) and/or reduce worsening in kidney function in those with kidney disease.
End date: 30th May 2025
Link to study on clinicaltrials.gov and here